Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1982 2
1983 2
1985 3
1986 3
1987 1
1988 1
1989 1
1990 3
1991 2
1992 2
1993 3
1994 1
1995 2
1996 2
1997 5
1998 4
1999 4
2000 9
2001 5
2002 8
2003 7
2004 6
2005 6
2006 3
2007 12
2008 10
2009 8
2010 8
2011 8
2012 21
2013 17
2014 25
2015 18
2016 18
2017 16
2018 21
2019 21
2020 15
2021 20
2022 17
2023 12
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

308 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Recurrent Primary Peritoneal Adenocarcinoma"
Page 1
Pseudomyxoma peritonei.
Hinson FL, Ambrose NS. Hinson FL, et al. Br J Surg. 1998 Oct;85(10):1332-9. doi: 10.1046/j.1365-2168.1998.00882.x. Br J Surg. 1998. PMID: 9782010 Review.
BACKGROUND: Pseudomyxoma peritonei is an unusual condition in which gelatinous fluid collections are associated with mucinous implants on the peritoneal surfaces and omentum. The pathological origin and ideal treatment of the condition are subjects of debate. ...RESULTS AN …
BACKGROUND: Pseudomyxoma peritonei is an unusual condition in which gelatinous fluid collections are associated with mucinous implants on th …
Genomic catastrophe, the peritoneal cavity and ovarian cancer prevention.
Yoon JY, Chapel DB, Goebel E, Qian X, Mito JK, Horowitz NS, Miron A, Soong TR, Xian W, Crum CP. Yoon JY, et al. J Pathol. 2022 Jul;257(3):255-261. doi: 10.1002/path.5891. Epub 2022 Apr 18. J Pathol. 2022. PMID: 35238033 Review.
The current theory of carcinogenesis for the deadliest of 'ovarian' cancers-high-grade serous carcinoma (HGSC)-holds that the malignancy develops first in the fallopian tube and spreads to the ovaries, peritoneum, and/or regional lymph nodes. This is based primarily on the …
The current theory of carcinogenesis for the deadliest of 'ovarian' cancers-high-grade serous carcinoma (HGSC)-holds that the malignancy dev …
Cytoreductive Surgery and Hyperthermic Peritoneal Chemotherapy in Appendiceal and Colorectal Cancer: Outcomes and Survival.
Djadou TM, Poh KS, Yellinek S, Fayazzadeh H, El-Hayek K, Simpfendorfer CH, DaSilva G, Wexner SD. Djadou TM, et al. Am Surg. 2023 Dec;89(12):5757-5767. doi: 10.1177/00031348231175452. Epub 2023 May 8. Am Surg. 2023. PMID: 37155318
Mean Peritoneal Cancer Index was 9.6 7.7; complete cytoreduction was achieved in 90.9%. 53.6% developed postoperative complications. ...Univariate analysis of preoperative chemotherapy, primary malignancy location, primary tumor perforated or obstructive, pos …
Mean Peritoneal Cancer Index was 9.6 7.7; complete cytoreduction was achieved in 90.9%. 53.6% developed postoperative complications. …
The 4th St. Gallen EORTC Gastrointestinal Cancer Conference: Controversial issues in the multimodal primary treatment of gastric, junctional and oesophageal adenocarcinoma.
Lutz MP, Zalcberg JR, Ducreux M, Adenis A, Allum W, Aust D, Carneiro F, Grabsch HI, Laurent-Puig P, Lordick F, Möhler M, Mönig S, Obermannova R, Piessen G, Riddell A, Röcken C, Roviello F, Schneider PM, Seewald S, Smyth E, van Cutsem E, Verheij M, Wagner AD, Otto F. Lutz MP, et al. Eur J Cancer. 2019 May;112:1-8. doi: 10.1016/j.ejca.2019.01.106. Epub 2019 Mar 15. Eur J Cancer. 2019. PMID: 30878666 Review.
Multimodal primary treatment of localised adenocarcinoma of the stomach, the oesophagus and the oesophagogastric junction (AEG) was reviewed by a multidisciplinary expert panel in a moderated consensus session. ...Their value is limited with respect to the infiltrat …
Multimodal primary treatment of localised adenocarcinoma of the stomach, the oesophagus and the oesophagogastric junction (AEG …
The Prediction of Recurrence in Low-Risk Endometrial Cancer: Is It Time for a Paradigm Shift in Adjuvant Therapy?
Laban M, El-Swaify ST, Ali SH, Refaat MA, Sabbour M, Farrag N, Hassanin AS. Laban M, et al. Reprod Sci. 2022 Apr;29(4):1068-1085. doi: 10.1007/s43032-021-00565-8. Epub 2021 Apr 15. Reprod Sci. 2022. PMID: 33856667 Review.
Five to 10% of patients with stage IA, grade 1 or 2, endometrioid adenocarcinoma subsequently develop locoregional or distant recurrence. ...A systematic search of the literature on PubMed and Medline was conducted using the following search terms: endometrial cance …
Five to 10% of patients with stage IA, grade 1 or 2, endometrioid adenocarcinoma subsequently develop locoregional or distant recu …
Real-world study of bevacizumab treatment in patients with ovarian cancer: a Chinese single-institution study of 155 patients.
Zhang N, Zheng H, Gao Y, Shu T, Wang H. Zhang N, et al. BMC Womens Health. 2023 Apr 13;23(1):178. doi: 10.1186/s12905-023-02329-9. BMC Womens Health. 2023. PMID: 37055754 Free PMC article. Review.
METHODS: We reviewed the clinicopathological data of patients with histologically confirmed epithelial ovarian cancer, fallopian tube cancer and primary peritoneal adenocarcinoma, who were diagnosed and treated at the Department of Gynecologic Oncology of Pek …
METHODS: We reviewed the clinicopathological data of patients with histologically confirmed epithelial ovarian cancer, fallopian tube cancer …
A comprehensive review of childbearing after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Papageorgiou D, Manatakis DK, Papakonstantinou K, Kyriazanos ID. Papageorgiou D, et al. Arch Gynecol Obstet. 2020 Oct;302(4):793-799. doi: 10.1007/s00404-020-05687-z. Epub 2020 Jul 11. Arch Gynecol Obstet. 2020. PMID: 32653946 Review.
The terms "Cytoreductive Surgery", "Hyperthermic Intraperitoneal Chemotherapy", "Peritoneal Carcinomatosis", "Pregnancy", "Fertility Preservation", "Conception" were used. ...Nine patients were treated for pseudomyxoma peritonei, four for primary peritoneal m …
The terms "Cytoreductive Surgery", "Hyperthermic Intraperitoneal Chemotherapy", "Peritoneal Carcinomatosis", "Pregnancy", "Fertility …
Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial.
Klaver CEL, Wisselink DD, Punt CJA, Snaebjornsson P, Crezee J, Aalbers AGJ, Brandt A, Bremers AJA, Burger JWA, Fabry HFJ, Ferenschild F, Festen S, van Grevenstein WMU, Hemmer PHJ, de Hingh IHJT, Kok NFM, Musters GD, Schoonderwoerd L, Tuynman JB, van de Ven AWH, van Westreenen HL, Wiezer MJ, Zimmerman DDE, van Zweeden AA, Dijkgraaf MGW, Tanis PJ; COLOPEC collaborators group. Klaver CEL, et al. Lancet Gastroenterol Hepatol. 2019 Oct;4(10):761-770. doi: 10.1016/S2468-1253(19)30239-0. Epub 2019 Jul 29. Lancet Gastroenterol Hepatol. 2019. PMID: 31371228 Clinical Trial.
Adjuvant HIPEC consisted of fluorouracil (400 mg/m(2)) and leucovorin (20 mg/m(2)) delivered intravenously followed by intraperitoneal delivery of oxaliplatin (460 mg/m(2)) for 30 min at 42C, delivered simultaneously or within 5-8 weeks after primary tumour resection. In a …
Adjuvant HIPEC consisted of fluorouracil (400 mg/m(2)) and leucovorin (20 mg/m(2)) delivered intravenously followed by intraperitoneal deliv …
Mucinous adenocarcinomas with intra-abdominal dissemination: a review of current therapy.
Winder T, Lenz HJ. Winder T, et al. Oncologist. 2010;15(8):836-44. doi: 10.1634/theoncologist.2010-0052. Epub 2010 Jul 23. Oncologist. 2010. PMID: 20656916 Free PMC article. Review.
However, a comprehensive treatment approach involving cytroreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) has evolved into a novel approach for peritoneal carcinomatosis. Surgery removes the primary cancer and any dissemination within the …
However, a comprehensive treatment approach involving cytroreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) has evolv …
Biomarkers expression among paired serous ovarian cancer primary lesions and their peritoneal cavity metastases in treatment-naive patients: A single-center study.
Nikas IP, Lee C, Song MJ, Kim B, Ryu HS. Nikas IP, et al. Cancer Med. 2022 Jun;11(11):2193-2203. doi: 10.1002/cam4.4600. Epub 2022 Feb 25. Cancer Med. 2022. PMID: 35212471 Free PMC article.
This retrospective study aimed to identify potential biomarker discrepancies between paired HGSOC primary tissues and metastatic peritoneal fluid cytology samples, processed as cell blocks (CBs). ...RESULTS: 13/24 pairs showed discordant EGFR IHC results; in all the …
This retrospective study aimed to identify potential biomarker discrepancies between paired HGSOC primary tissues and metastatic p …
308 results